Friday, 13 September 2013

Uganda Pharmaceuticals and Healthcare Report Q4 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed 
Make Money From Your Roof

We are paying to help homeowners profit from producing solar power. Find out if your home qualifies for our program today. Sign up!
From our sponsors
Uganda Pharmaceuticals and Healthcare Report Q4 2013
Sep 11th 2013, 00:00

Price: $ 1295  

BMI View: Investment into Uganda's pharmaceuticals and healthcare sector by companies to meet the demand for healthcare services is an advisable business strategy - as highlighted by the high growth forecast in healthcare spending between 2012 and 2017. However, we note that there are downside risks to our forecast. These include low affordability levels, inadequate healthcare infrastructure and inefficient supply chain systems, which will ultimately inhibit drugmakers' revenue-earning abilities. Headline Expenditure Projections ? Pharmaceuticals: UGX831.90bn (US$332mn) in 2012 to UGX926.84(US$348mn) in 2013; +11.4% growth in local currency terms and +4.2% in US dollar terms. ? Healthcare: UGX4,154.02bn (US$1.66bn) in 2012 to UGX4,504.76 (US$1.69bn) in 2013; 8.4% growth in local curren ...

Complete report details with Table of Contents and more @

Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment